DMAB-anabaseine dihydrochloride
CAS No. 154149-38-9
DMAB-anabaseine dihydrochloride( N,N-dimethyl-4-[(E)-(6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene)methyl]aniline | dihydrochloride )
Catalog No. M27623 CAS No. 154149-38-9
DMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 72 | In Stock |
|
| 5MG | 107 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 261 | In Stock |
|
| 50MG | 366 | In Stock |
|
| 100MG | 535 | In Stock |
|
| 200MG | 724 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDMAB-anabaseine dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
-
DescriptionDMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
-
In Vitro——
-
In Vivo——
-
SynonymsN,N-dimethyl-4-[(E)-(6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene)methyl]aniline | dihydrochloride
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number154149-38-9
-
Formula Weight364.31
-
Molecular FormulaC19H23Cl2N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CN(C)c1ccc(\C=C2/CCCN=C2c2cccnc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.1. Nouioua S, et al. Creatine deficiency syndrome. A treatable myopathy due to arginine-glycine amidinotransferase (AGAT) deficiency. Neuromuscul Disord. 2013 Aug;23(8):670-4.
molnova catalog
related products
-
SCH 57790
SCH 57790 is a novel and selective muscarinic M(2) receptor antagonist that releases acetylcholine and enhances cognition in experimental animals for the treatment of Alzheimer's disease.
-
SSR180711 hydrochlor...
SSR180711 hydrochloride (SSR-180711A HCl) is a selective Alpha7 nicotinic acetylcholine partial agonist for the study of neurodegenerative and cognitive disorders.
-
VU0152099
VU0152099 is a potent and selective M4 mAChR allosteric potentiator(EC50 = 380 ± 93 nM).
Cart
sales@molnova.com